Tuesday, August 30, 2016

BRIEF-Oncolys BioPharma applies phase II clinical trial of OBP-301 in U.S

* Says it submitted clinical trial plan (protocol) to the

United States Food and Drug Administration for phase II clinical

trial of oncolytic virus OBP-301 (Telomelysin) in U.S

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)